Publications:

JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCL.

Blood Advances

Yumeen, Sara S; Mirza, Fatima N FN; Lewis, Julia M JM; King, Amber Loren O ALO; Kim, Sa Rang SR; Carlson, Kacie R KR; Umlauf, Sheila R SR; Surovtseva, Yulia V YV; Foss, Francine M FM; Girardi, Michael M

Publication Date: 2020-05-26

Variant appearance in text: DNMT3A: E94A

PubMed Link: 32437546

Variant Present in the following documents:

• Main text

View BVdb publication page

AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting.

Bmc Medical Genomics

Wünsch, Christian C; Banck, Henrik H; Müller-Tidow, Carsten C; Dugas, Martin M

Publication Date: 2020-02-04

Variant appearance in text: DNMT3A: 281A>C; E94A

PubMed Link: 32019565

Variant Present in the following documents:

• 12920_2020_668_MOESM6_ESM.xls, sheet 1

View BVdb publication page

appreci8: a pipeline for precise variant calling integrating 8 tools.

Bioinformatics (Oxford, England)

Sandmann, Sarah S; Karimi, Mohsen M; de Graaf, Aniek O AO; Rohde, Christian C; Göllner, Stefanie S; Varghese, Julian J; Ernsting, Jan J; Walldin, Gunilla G; van der Reijden, Bert A BA; Müller-Tidow, Carsten C; Malcovati, Luca L; Hellström-Lindberg, Eva E; Jansen, Joop H JH; Dugas, Martin M

Publication Date: 2018-12-15

Variant appearance in text: DNMT3A: 281A>C; Glu94Ala

PubMed Link: 29945233

Variant Present in the following documents:

• bty518_supplementary_data_s4.xlsx, sheet 8

View BVdb publication page